← Back to Search

Resistant Starch

RS4 bar for Obesity

N/A
Waitlist Available
Led By Sara Rosenkranz, PhD
Research Sponsored by Kansas State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI ≥ 23 kg/m2
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0,4, and 8
Awards & highlights

Study Summary

This trial will study the effects of long-term consumption of a fiber supplement on blood lipids and body composition in order to determine its potential for preventing obesity and obesity-related diseases.

Eligible Conditions
  • Overweight or Obesity
  • High Cholesterol

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You weigh more than what is considered healthy for your height.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0,4, and 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0,4, and 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in plasma lipids
Secondary outcome measures
Change in BMI
Change in body composition
Change in homeostatic model assessment for insulin resistance (HOMA-IR)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Resistant starch barExperimental Treatment1 Intervention
The RS4 group will consume one nutrition bar per day formulated using Fibersym® RW.
Group II: Native wheat barActive Control1 Intervention
The control group will consume one native wheat starch bar per day.

Find a Location

Who is running the clinical trial?

MGP Ingredients, Inc.Industry Sponsor
4 Previous Clinical Trials
48 Total Patients Enrolled
Kansas State UniversityLead Sponsor
35 Previous Clinical Trials
13,217 Total Patients Enrolled
6 Trials studying Obesity
6,453 Patients Enrolled for Obesity
Sara Rosenkranz, PhDPrincipal InvestigatorKansas State University
2 Previous Clinical Trials
85 Total Patients Enrolled
1 Trials studying Obesity
48 Patients Enrolled for Obesity

Media Library

Fibersym® RW (Resistant Starch) Clinical Trial Eligibility Overview. Trial Name: NCT04277741 — N/A
Obesity Research Study Groups: Native wheat bar, Resistant starch bar
Obesity Clinical Trial 2023: Fibersym® RW Highlights & Side Effects. Trial Name: NCT04277741 — N/A
Fibersym® RW (Resistant Starch) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04277741 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many subjects are engaged in this research endeavor?

"Affirmative. As evidenced on clinicaltrials.gov, this medical experiment is currently searching for suitable participants and was first made available to the public on February 18th 2020. The last update took place in August 15th 2022 and 50 patients are needed at a single site."

Answered by AI

Are any new participants being accepted for the study at present?

"Affirmative. According to the information documented on clinicaltrials.gov, this medical trial that was initially posted on February 18th 2020 is recruiting patients at present. The research team seeks 50 individuals from a single centre."

Answered by AI

Who meets the eligibility criteria for participating in this research?

"To be eligible to enter this trial, volunteers must comprise a BMI above the norm and fall within the ages of 18-65. The study is looking for roughly 50 participants."

Answered by AI

Who else is applying?

What state do they live in?
Kansas
What site did they apply to?
Physical Activity and Nutrition Clinical Research Consortium
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
~0 spots leftby Mar 2025